Flow Neuroscience vs Apollo Neuro — Side-by-Side

Flow Neuroscience vs Apollo Neuro (2026)

Flow Neuroscience and Apollo Neuro are two devices that look similar on a feature list — both wearable, both targeting mood and stress — but are not really the same kind of product. Flow is a medical device for major depression — FDA premarket approval (PMA P230024, December 2025) and CE-marked as Class IIa in the EU — delivering transcranial direct-current stimulation (tDCS) under a clinical protocol. Apollo Neuro is a vibrotactile wellness wearable marketed for calm, without a clinical indication. Different categories, often compared.

Flow Neuroscience or Apollo Neuro: which is better?

Higher ONDA score: Apollo Neuro (7.1 vs 6.7)

Not really substitutes. Flow Neuroscience for tDCS depression treatment under a structured programme. Apollo Neuro for all-day vibrotactile wear, marketed for calm, in general wellness use.

Head-to-head breakdown

Flow Neuroscience vs Apollo Neuro — head-to-head comparison by criterion
Criterion	Winner	Why
Regulatory status	Flow Neuroscience	Flow Neuroscience: FDA premarket approval (PMA P230024, 8 December 2025, MDD in adults not treatment-refractory) and CE-marked Class IIa medical device. Apollo Neuro: consumer wellness wearable, no medical-device clearance. Flow is the regulated option.
Mechanism	Flow Neuroscience	Flow: tDCS — 2 mA direct-current stimulation over the dorsolateral prefrontal cortex (active intervention). Apollo: vibrotactile stimulation via skin mechanoreceptors (the maker says it engages the vagus nerve). Flow is more direct.
Indication scope	Apollo Neuro	Flow: indicated only for major depression. Apollo: general wellness — recovery, focus, sleep, calm. Apollo is broader-use; Flow is narrower by design.
Clinical evidence	Flow Neuroscience	Flow: a fully remote randomised sham-controlled trial in Nature Medicine (Woodham 2024, funded by Flow) for tDCS in major depression. Apollo: University of Pittsburgh HRV/recovery RCTs. Both real; Flow’s trials are in a clinical population (major depression).
Day-to-day use frequency	Apollo Neuro	Apollo: continuous daily wear. Flow: 30-minute structured sessions in an 8-week programme. Apollo runs in the background; Flow is foreground intervention.
Wearability	Apollo Neuro	Apollo: wrist/ankle/clip-on for 24/7 wear. Flow: rigid headset for seated sessions only. Apollo wins on daily life integration.
Programme structure	Flow Neuroscience	Flow: structured 8-week behavioural-therapy programme combined with stimulation. Apollo: open-ended mode selection. Flow has the clinical scaffolding.
Price	Apollo Neuro	Apollo: $448 incl. a 1-year SmartVibes AI membership. Flow: £399 (~$499) + monthly therapy-app subscription. Apollo is cheaper with no required ongoing subscription.

Choose Flow Neuroscience

Choose Flow Neuroscience if you have major depression and a clinician open to a tDCS option — FDA-approved (PMA P230024) and CE-marked, with randomised-trial evidence.

Choose Apollo Neuro

Choose Apollo Neuro if you want a passive vibrotactile wearable marketed for calm through your day — general wellness, recovery, stress — without a clinical indication or programme commitment.

The short version

Flow Neuroscience and Apollo Neuro look adjacent but are not really substitutes. Flow is an FDA-approved, CE-marked clinical device for diagnosed major depression; Apollo is a consumer wellness wearable marketed for calm. The decision is whether you have a clinical condition or a wellness intent.

When is Flow Neuroscience the right pick?

If you have major depression and a clinician open to discussing tDCS as a take-home option, Flow is the right shape. The FDA approval and CE marking, the randomised trial in Nature Medicine (Woodham 2024), and the structured 8-week behavioural-therapy programme are the value. For general wellness this is the wrong tool — the indication is narrow on purpose.

When is Apollo Neuro the right pick?

If you want a passive vibrotactile wearable marketed for calm through the day — for recovery, stress, sleep, focus — without a clinical indication or a structured programme commitment, Apollo is the right shape. It is vibrotactile, marketed for calm, backed by founder-led University of Pittsburgh research; daily wearability is the use case.

Common questions

Should I pick Flow Neuroscience or Apollo Neuro?

They solve different problems. Flow if you have major depression and a clinician open to tDCS as a take-home option — Flow is an FDA-approved, CE-marked tDCS device with a structured behavioural-therapy programme. Apollo if you want a vibrotactile wearable marketed for calm throughout the day without a clinical indication.

Is Flow Neuroscience FDA-approved?

Yes, for one indication. The FDA granted premarket approval to the Flow FL-100 (PMA P230024, 8 December 2025) for moderate-to-severe major depressive disorder in adults who are not treatment-refractory. Flow is also CE-marked in Europe as a Class IIa medical device and prescribed within parts of the UK NHS. Apollo Neuro is sold as a consumer wellness device, without FDA clearance.

Can I treat my own depression with Apollo Neuro?

Apollo Neuro is not indicated for any clinical condition. For diagnosed depression, Flow Neuroscience is the regulated option; Apollo is for wellness use only. The two should not be conflated.

Should I use both?

In theory the mechanisms (active tDCS vs passive vibrotactile) don’t overlap. In practice, if you have clinical depression Flow is the right tool under medical guidance; Apollo is for general wellness alongside it. The combination is unusual.

Flow Neuroscience vs Apollo Neuro (2026)

Flow Neuroscience or Apollo Neuro: which is better?